A detailed history of Penserra Capital Management LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Penserra Capital Management LLC holds 126 shares of BSX stock, worth $11,397. This represents 0.0% of its overall portfolio holdings.

Number of Shares
126
Previous 120 5.0%
Holding current value
$11,397
Previous $9,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$72.96 - $84.0 $437 - $504
6 Added 5.0%
126 $10,000
Q1 2024

May 15, 2024

SELL
$57.6 - $68.62 $383,328 - $456,666
-6,655 Reduced 98.23%
120 $8,000
Q4 2023

Feb 14, 2024

SELL
$48.64 - $57.81 $69,312 - $82,379
-1,425 Reduced 17.38%
6,775 $390,000
Q3 2023

Nov 15, 2023

SELL
$50.19 - $54.68 $55,911 - $60,913
-1,114 Reduced 11.96%
8,200 $432,000
Q2 2023

Aug 11, 2023

BUY
$49.72 - $54.64 $459,213 - $504,655
9,236 Added 11841.03%
9,314 $503,000
Q4 2022

Feb 13, 2023

BUY
$39.56 - $47.22 $3,085 - $3,683
78 New
78 $3,000
Q2 2022

Aug 15, 2022

SELL
$35.24 - $47.1 $24,104 - $32,216
-684 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$40.9 - $45.1 $12,515 - $13,800
-306 Reduced 30.91%
684 $30,000
Q4 2021

Feb 15, 2022

SELL
$38.07 - $44.87 $7,309 - $8,615
-192 Reduced 16.24%
990 $42,000
Q3 2021

Nov 15, 2021

BUY
$41.23 - $45.88 $28,118 - $31,290
682 Added 136.4%
1,182 $51,000
Q2 2021

Aug 12, 2021

BUY
$38.58 - $44.24 $19,290 - $22,120
500 New
500 $21,000
Q3 2019

Nov 15, 2019

SELL
$40.31 - $43.45 $126,976 - $136,867
-3,150 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$34.91 - $42.98 $109,966 - $135,387
3,150 New
3,150 $135,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.